Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives
Abstract Africa carries a high burden of infectious diseases. Every year, millions of Africans contract tuberculosis, malaria, and many other diseases. Malaria kills hundreds of thousands of children under the age of five years annually. More than 11,000 people died during the 2014–2016 Ebola outbre...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2022-06-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202216287 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849761853112057856 |
|---|---|
| author | AbdulRahman A Saied Asmaa A Metwally Manish Dhawan Om Prakash Choudhary Hani Aiash |
| author_facet | AbdulRahman A Saied Asmaa A Metwally Manish Dhawan Om Prakash Choudhary Hani Aiash |
| author_sort | AbdulRahman A Saied |
| collection | DOAJ |
| description | Abstract Africa carries a high burden of infectious diseases. Every year, millions of Africans contract tuberculosis, malaria, and many other diseases. Malaria kills hundreds of thousands of children under the age of five years annually. More than 11,000 people died during the 2014–2016 Ebola outbreak in West Africa; still, occasional cases of Ebola, as well as monkeypox, periodically appear in the Democratic Republic of Congo. Since most of the African countries gained their independence during the 1960s, the continent has relied heavily on the outside world for diagnostics, medicines, vaccines, personal protective equipment, and other medical supplies. Africa consumes nearly 25% of the globally produced vaccines but imports 99% and 95% of its vaccines and medicines, respectively. The 55 African countries were not able to ensure the health of 1.3 billion Africans during the COVID‐19 pandemic but had to rely on other global initiatives and other countries for help and support. However, the pandemic and the shortage of vaccines may have been the much‐needed trigger for this situation to change. “When misfortunes increase, they erase each other.” Naguib Mahfouz (1911–2006). |
| format | Article |
| id | doaj-art-da7acc1098984a12b03e6c61c90f608f |
| institution | DOAJ |
| issn | 1757-4676 1757-4684 |
| language | English |
| publishDate | 2022-06-01 |
| publisher | Springer Nature |
| record_format | Article |
| series | EMBO Molecular Medicine |
| spelling | doaj-art-da7acc1098984a12b03e6c61c90f608f2025-08-20T03:05:54ZengSpringer NatureEMBO Molecular Medicine1757-46761757-46842022-06-011481610.15252/emmm.202216287Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectivesAbdulRahman A Saied0Asmaa A Metwally1Manish Dhawan2Om Prakash Choudhary3Hani Aiash4National Food Safety Authority (NFSA)Department of Surgery, Anesthesiology, and Radiology, Faculty of Veterinary Medicine, Aswan UniversityDepartment of Microbiology, Punjab Agricultural UniversityDepartment of Veterinary Anatomy and Histology, College of Veterinary Sciences and Animal Husbandry, Central Agricultural University (I), SelesihDepartment of Family Medicine, Suez Canal UniversityAbstract Africa carries a high burden of infectious diseases. Every year, millions of Africans contract tuberculosis, malaria, and many other diseases. Malaria kills hundreds of thousands of children under the age of five years annually. More than 11,000 people died during the 2014–2016 Ebola outbreak in West Africa; still, occasional cases of Ebola, as well as monkeypox, periodically appear in the Democratic Republic of Congo. Since most of the African countries gained their independence during the 1960s, the continent has relied heavily on the outside world for diagnostics, medicines, vaccines, personal protective equipment, and other medical supplies. Africa consumes nearly 25% of the globally produced vaccines but imports 99% and 95% of its vaccines and medicines, respectively. The 55 African countries were not able to ensure the health of 1.3 billion Africans during the COVID‐19 pandemic but had to rely on other global initiatives and other countries for help and support. However, the pandemic and the shortage of vaccines may have been the much‐needed trigger for this situation to change. “When misfortunes increase, they erase each other.” Naguib Mahfouz (1911–2006).https://doi.org/10.15252/emmm.202216287AfricaCOVID‐19manufacturingmRNA vaccinevaccines |
| spellingShingle | AbdulRahman A Saied Asmaa A Metwally Manish Dhawan Om Prakash Choudhary Hani Aiash Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives EMBO Molecular Medicine Africa COVID‐19 manufacturing mRNA vaccine vaccines |
| title | Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives |
| title_full | Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives |
| title_fullStr | Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives |
| title_full_unstemmed | Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives |
| title_short | Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives |
| title_sort | strengthening vaccines and medicines manufacturing capabilities in africa challenges and perspectives |
| topic | Africa COVID‐19 manufacturing mRNA vaccine vaccines |
| url | https://doi.org/10.15252/emmm.202216287 |
| work_keys_str_mv | AT abdulrahmanasaied strengtheningvaccinesandmedicinesmanufacturingcapabilitiesinafricachallengesandperspectives AT asmaaametwally strengtheningvaccinesandmedicinesmanufacturingcapabilitiesinafricachallengesandperspectives AT manishdhawan strengtheningvaccinesandmedicinesmanufacturingcapabilitiesinafricachallengesandperspectives AT omprakashchoudhary strengtheningvaccinesandmedicinesmanufacturingcapabilitiesinafricachallengesandperspectives AT haniaiash strengtheningvaccinesandmedicinesmanufacturingcapabilitiesinafricachallengesandperspectives |